|
||||||
| HOME | MODULES | GLOSSARY | CONTACT | RESOURCES | REFERENCES |
|
| Home --> Modules -->Module 2 | ||||||
Module 2: Screening and Assessment5F. Assessment of Co-occurring DisordersIf symptoms of both mental health and substance use disorders are detected during screening, all follow-up assessments should explore both disorders. Symptoms of mental health and substance use disorders can mimic, mask, precipitate, or exacerbate each other. Understanding the interactive effects of these disorders is critical to the development of a successful treatment plan. Clarifying the chronology of substance use and mental health symptoms is important as is continued reassesment and rediagnosis. Whenever possible, it is important to clarify the chronology of the relationship between co-occurring mental health and substance use disorders. Use the checkboxes below to indicate which steps your agency typically does. If significant psychiatric symptoms continue after a detoxification period (how long depends on the pattern and type of substance used), treatment planning must consider explanations other than substance-induced causes. How Important Is the Issue of "Primary" Versus "Secondary" Diagnosis? This has been a prominent issue in the history and treatment of youth with co-occurring disorders. One school of thought was that treating the "primary" disorder of mental illness would be enough to resolve the youths substance use disorder. This strategy has been found to be both simplistic and futile, with most youth with co-occurring disorders failing to make expected treatment gains or achieve symptom remission because their continued abuse of substances remained unaddressed. Historically, this distinction has been used to deny services and shift youth from one system to another. Currently, most experts feel the distinction is not very useful in making treatment decisions. Continual Reassessment and Rediagnosis The wide variation in co-occurring disorders and the impact of adolescent development create a need to continually assess symptoms, the course of the disorders, and the effectiveness of the treatment being provided. In addition, substance use in one environment does not predict substance use in the next setting. Only with continual reassessment and rediagnosis are we able to monitor the disorders closely and work to prevent relapse.
|
||||||
|
© 2001 Policy Research Associates, Inc. All rights reserved |
||||||